Our group previously reported the efficacy of antisense-mediated dystrophin exons 45–55 skipping and rescue of dystrophin protein in vivo using a cocktail of vivo-morpholinos (vPMOs) in a mouse model of DMD [14, 15]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.